BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27313102)

  • 1. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
    Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
    NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Kawashima H; Miyati T; Ohno N; Ohno M; Inokuchi M; Ikeda H; Gabata T
    Acad Radiol; 2017 Dec; 24(12):1575-1581. PubMed ID: 28778511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
    Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
    Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
    Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
    Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
    Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
    Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 3.0 Tesla diffusion tensor Imaging parameters be prognostic indicators in breast cancer?
    Ozal ST; Inci E; Gemici AA; Turgut H; Cikot M; Karabulut M
    Clin Imaging; 2018; 51():240-247. PubMed ID: 29886409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
    Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
    J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index.
    Lee JH; Yoon YC; Seo SW; Choi YL; Kim HS
    Eur Radiol; 2020 Feb; 30(2):914-924. PubMed ID: 31630234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla.
    Liu F; Wang M; Li H
    World J Surg Oncol; 2018 Dec; 16(1):239. PubMed ID: 30577820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status.
    Xiao Z; Zhong Y; Tang Z; Qiang J; Qian W; Wang R; Wang J; Wu L; Tang W; Zhang Z
    Eur Radiol; 2018 Jul; 28(7):2923-2933. PubMed ID: 29383521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.